Teriflunomide as a therapeutic means for myelin repair

Abstract Background Promotion of myelin repair in the context of demyelinating diseases such as multiple sclerosis (MS) still represents a clinical unmet need, given that this disease is not only characterized by autoimmune activities but also by impaired regeneration processes. Hence, this relates...

Full description

Bibliographic Details
Published in:Journal of Neuroinflammation
Main Authors: Peter Göttle, Janos Groh, Laura Reiche, Joel Gruchot, Nicole Rychlik, Luisa Werner, Iria Samper Agrelo, Rainer Akkermann, Annika Zink, Alessandro Prigione, Hans-Peter Hartung, Rudolf Martini, Patrick Küry
Format: Article
Language:English
Published: BMC 2023-01-01
Subjects:
Multiple sclerosis
Teriflunomide
Oligodendrocyte
Remyelination
Neuroregeneration
Online Access:https://doi.org/10.1186/s12974-022-02686-6

Internet

https://doi.org/10.1186/s12974-022-02686-6

Similar Items